Dr. David S. Wilkes Appointed to Syneos Health Board of Directors
June 16, 2021 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., June 16, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of David S....
Syneos Health Launches Patient Voice Consortium
June 03, 2021 10:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., June 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today launched its Patient Voice Consortium....
Syneos Health Announces Pricing of Secondary Offering of Common Stock
June 03, 2021 05:19 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., June 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization, today...
Syneos Health Announces Secondary Offering of Common Stock
June 02, 2021 16:01 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., June 02, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization, today...
Syneos Health to Present at Upcoming Investor Conferences
May 21, 2021 13:51 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 21, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced that the Company is scheduled to...
Syneos Health Leaders Recognized For Visionary Healthcare Expertise Through HBA
May 06, 2021 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 06, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Lynn Hamilton, Senior...
Syneos Health Announces Pricing of Secondary Offering of Common Stock
May 03, 2021 21:33 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization, today...
Syneos Health Announces Secondary Offering of Common Stock
May 03, 2021 16:40 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization, today...
Syneos Health Launches “Lab to Life” Enterprise Partnership with Komodo Health
May 03, 2021 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced today it has expanded its relationship...
Illingworth Research Group Recognized with Queen’s Award for Enterprise: International Trade 2021
April 30, 2021 05:05 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 30, 2021 (GLOBE NEWSWIRE) -- The Illingworth Research Group, a Syneos Health® company, has been recognized with a 2021 Queen’s Award for Enterprise for International Trade....